The Foundation’s award will support preclinical studies of a potential phage therapy to treat resistant Pseudomonas infections.
Site Search
More than 160 people with CF and their loved ones from across the country advocated for a more robust antibiotics pipeline during the CF Foundation's virtual March on the Hill.
This milestone was reached nearly two years ahead of the initiative’s five-year commitment. However, the Foundation aims to continue to support infection research at the same pace as it has in the past three years.
Dr. Steven Rowe will support mission to cure cystic fibrosis by leading the Foundation’s research strategy, focusing on genetic therapies
Foundation to fund up to $110 million for collaboration to accelerate the development of genetic therapies for CF
The treatment has the potential to prevent Aspergillus fungal infections in people who have had a lung transplant.
Addressing variability in newborn screening can prevent missed diagnoses and delays in early care intervention.
More than 60 teens from across the country — 25 of whom live with cystic fibrosis — participated online and on Capitol Hill in the Foundation’s Teen Advocacy Day to advocate for the CF community.
The Foundation and Bakar Labs will support AVECRIS Pte Ltd and Nosis Biological Sciences as they pursue genetic therapies for cystic fibrosis with their novel technologies.